ZEVRA THERAPEUTICS INC (ZVRA) Stock Analyst Earnings Estimates
NASDAQ:ZVRA - Nasdaq - US4884452065 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 28.65M 115.58% | 10.46M -63.49% | 27.461M 162.53% | 20.925M -23.80% | 89.986M 330.04% | 178.15M 97.98% | 275.53M 54.66% | 356.59M 29.42% | 379.32M 6.37% | 414.2M 9.20% | 469.83M 13.43% | 532.51M 13.34% | |
| EBITDA YoY % growth | 7.99M 262.07% | -23.91M -399.25% | -48.598M -103.25% | -90.168M -85.54% | -20.808M 76.92% | 28.968M 239.22% | 127.5M 340.14% | 262.14M 105.60% | 352.1M 34.32% | 499.19M 41.78% | 635.46M 27.30% | N/A | |
| EBIT YoY % growth | 7.73M 248.65% | -24.85M -421.47% | -49.604M -99.61% | -92.791M -87.06% | -27.446M 70.42% | 50.43M 283.74% | 143.95M 185.45% | 211.65M 47.03% | 235.75M 11.39% | 263.93M 11.95% | 307.75M 16.60% | 353.03M 14.71% | |
| Operating Margin | 26.98% | -237.57% | -180.63% | -443.44% | -30.50% | 28.31% | 52.24% | 59.35% | 62.15% | 63.72% | 65.50% | 66.30% | |
| EPS YoY % growth | -0.46 86.10% | -0.69 -50.00% | -1.29 -86.96% | -2.03 -57.00% | -0.34 83.14% | 0.78 329.52% | 2.24 185.99% | 3.22 43.77% | 3.58 11.08% | 3.85 7.41% | 4.39 14.06% | 5.21 18.68% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.41 -3.08% | 0.04 109.35% | -0.18 62.05% | -0.12 82.26% | -0.06 84.45% | 0.06 63.62% | 0.16 189.60% | 0.14 216.67% | 0.19 402.26% |
| Revenue Q2Q % growth | 9.104M -31.12% | 16.335M 376.93% | 21.591M 385.30% | 25.178M 581.41% | 28.91M 217.55% | 40.888M 150.31% | 44.414M 105.71% | 47.044M 86.85% | 48.816M 68.86% |
| EBITDA Q2Q % growth | -23.562M -72.43% | -8.262M 56.34% | -5.814M 71.87% | -3.978M 82.37% | -2.754M 88.31% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.935M -42.70% | -12.829M 37.38% | -8.697M 63.45% | -5.74M 78.98% | -2.66M 87.29% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.69 -72.50% | -0.43 | -0.26 | -60.59% |
| Q2 2024 Q2Q % growth | -0.48 -220.00% | -0.44 | -0.04 | -8.43% |
| Q1 2024 Q2Q % growth | -0.40 -17.65% | -0.49 | 0.09 | 17.96% |
| Q4 2023 Q2Q % growth | -0.40 -53.85% | -0.27 | -0.13 | -46.15% |
| Q3 2023 Q2Q % growth | -0.40 -110.53% | -0.30 | -0.10 | -31.82% |
| Q2 2023 Q2Q % growth | -0.15 21.05% | -0.35 | 0.20 | 57.17% |
| Q1 2023 Q2Q % growth | -0.34 -580.00% | -0.24 | -0.10 | -43.37% |
| Q4 2022 Q2Q % growth | -0.26 -225.00% | -0.18 | -0.08 | -47.06% |
| Q3 2022 Q2Q % growth | -0.19 -280.00% | -0.13 | -0.06 | -43.29% |
| Q2 2022 Q2Q % growth | -0.19 -190.48% | -0.12 | -0.07 | -55.23% |
| Q1 2022 Q2Q % growth | -0.05 90.74% | -0.06 | 0.01 | 10.87% |
| Q4 2021 Q2Q % growth | -0.08 92.52% | -0.08 | 0.00 | -4.58% |
| Q3 2021 Q2Q % growth | -0.05 92.19% | -0.08 | 0.03 | 34.64% |
| Q2 2021 Q2Q % growth | 0.21 31.25% | 0.23 | -0.02 | -8.50% |
| Q1 2021 Q2Q % growth | -0.54 69.32% | -0.17 | -0.37 | -211.42% |
| Q4 2020 Q2Q % growth | -1.07 -568.75% | -0.65 | -0.42 | -63.91% |
| Q3 2020 Q2Q % growth | -0.64 -166.67% | -0.82 | 0.18 | 21.57% |
| Q2 2020 Q2Q % growth | 0.16 103.03% | 0.00 | 0.16 | % |
| Q1 2020 Q2Q % growth | -1.76 76.09% | 0.16 | -1.92 | -1,178.43% |
| Q4 2019 Q2Q % growth | -0.16 | -1.39 | 1.23 | 88.47% |
| Q3 2019 Q2Q % growth | 0.96 | -3.05 | 4.01 | 131.51% |
| Q2 2019 Q2Q % growth | -5.28 | -6.94 | 1.66 | 23.88% |
| Q1 2019 Q2Q % growth | -7.36 | -7.51 | 0.15 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 3.695M 27.63% | 4.966M | -1.271M | -25.59% |
| Q2 2024 Q2Q % growth | 4.449M -47.47% | 4.443M | 6K | 0.14% |
| Q1 2024 Q2Q % growth | 3.425M 18.96% | 3.839M | -414K | -10.78% |
| Q4 2023 Q2Q % growth | 13.217M 469.70% | 11.973M | 1.244M | 10.39% |
| Q3 2023 Q2Q % growth | 2.895M 0.87% | 3.447M | -552K | -16.01% |
| Q2 2023 Q2Q % growth | 8.47M 551.54% | 3.094M | 5.376M | 173.76% |
| Q1 2023 Q2Q % growth | 2.879M -27.48% | 2.708M | 171K | 6.31% |
| Q4 2022 Q2Q % growth | 2.32M -10.08% | 3.264M | -944K | -28.92% |
| Q3 2022 Q2Q % growth | 2.87M 45.69% | 3.264M | -394K | -12.07% |
| Q2 2022 Q2Q % growth | 1.3M -89.16% | 1.836M | -536K | -29.19% |
| Q1 2022 Q2Q % growth | 3.97M -67.24% | 3.126M | 844K | 27.00% |
| Q4 2021 Q2Q % growth | 2.58M 8.86% | 2.28M | 300K | 13.16% |
| Q3 2021 Q2Q % growth | 1.97M 2.07% | 2.228M | -258K | -11.58% |
| Q2 2021 Q2Q % growth | 11.99M 73.52% | 12.342M | -352K | -2.85% |
| Q1 2021 Q2Q % growth | 12.12M 479.90% | 2.142M | 9.978M | 465.83% |
| Q4 2020 Q2Q % growth | 2.37M 71.74% | 2.04M | 330K | 16.18% |
| Q3 2020 Q2Q % growth | 1.93M -83.16% | 1.938M | -8K | -0.41% |
| Q2 2020 Q2Q % growth | 6.91M | 6.885M | 25K | 0.36% |
| Q1 2020 Q2Q % growth | 2.09M | 5.916M | -3.826M | -64.67% |
| Q4 2019 Q2Q % growth | 1.38M | 5.66M | -4.28M | -75.62% |
| Q3 2019 Q2Q % growth | 11.46M | 2.992M | 8.468M | 283.02% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.22% | -88.02% | 0.29% | -18.79% |
| Revenue | 2.36% | -43.05% | 0.27% | -12.37% |